RECRUITING

Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Determine 1) the impact of abnormal fetal cerebrovascular physiology with neurodevelopmental delay (ND) outcomes and 2) how this relationship is modified by patient and environmental factors such as chronic congenital heart disease (CCHD) lesion, maternal-fetal environment, and social determinants of heath (SDOH) in a diverse population using a multicenter design. Pregnant women will be approached during one of their fetal cardiology clinic visits.

Official Title

Fetal Cerebrovascular Autoregulation in Congenital Heart Disease and Association With Neonatal Neurobehavior

Quick Facts

Study Start:2021-12-17
Study Completion:2024-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05767385

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:0 Years to 52 Years
Sexes Eligible for Study:FEMALE
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. * Pregnant women 18 years of age and over with a singleton fetus with known or suspected congenital heart disease anticipated to need intervention or surgery within 30 days of birth.
  1. * Known fetal chromosomal or genetic abnormalities
  2. * Multiple gestation pregnancy
  3. * Fetal extra-cardiac anomalies

Contacts and Locations

Study Contact

Whitnee Hogan, MD
CONTACT
801-213-3599
whitnee.hogan@hsc.utah.edu
Lisa M. Hansen, BA
CONTACT
801-587-9104
lisa.hansen@hsc.utah.edu

Study Locations (Sites)

University of California San Francisco
San Francisco, California, 94143
United States
Children's National Medical Center
Washington, District of Columbia, 20010
United States
Maine Medical Center
Scarborough, Maine, 04074
United States
Primary Children's Hospital
Salt Lake City, Utah, 84113
United States
University of Utah
Salt Lake City, Utah, 84132
United States

Collaborators and Investigators

Sponsor: University of Utah

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-12-17
Study Completion Date2024-12

Study Record Updates

Study Start Date2021-12-17
Study Completion Date2024-12

Terms related to this study

Keywords Provided by Researchers

  • Congenital Heart Disease
  • Maternal Fetal
  • Neonatal Neurodevelopment

Additional Relevant MeSH Terms

  • Congenital Heart Disease in Children
  • Hypoxia
  • Neurodevelopmental Disorders
  • Complex Congenital Heart Disease